BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 41 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,087,408 | -1.6% | 1,120,000 | 0.0% | 0.02% | 0.0% |
| Q2 2023 | $1,104,578 | -4.0% | 1,120,000 | 0.0% | 0.02% | -15.4% |
| Q1 2023 | $1,150,498 | -83.4% | 1,120,000 | -83.5% | 0.03% | -86.9% |
| Q2 2018 | $6,913,000 | +8.1% | 6,800,000 | 0.0% | 0.20% | +6.5% |
| Q1 2018 | $6,395,000 | -5.9% | 6,800,000 | 0.0% | 0.19% | -4.6% |
| Q4 2017 | $6,794,000 | -14.3% | 6,800,000 | -12.8% | 0.20% | -13.7% |
| Q3 2017 | $7,924,000 | – | 7,800,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 16,298,000 | $15,340,000 | 1.64% |
| ZAZOVE ASSOCIATES LLC | 25,540,000 | $24,103,000 | 1.55% |
| PIER 88 INVESTMENT PARTNERS LLC | 3,030,000 | $2,844,000 | 1.36% |
| Jabre Capital Partners S.A. | 5,500,000 | $5,184,000 | 1.12% |
| Sonora Investment Management, LLC | 7,100,000 | $6,681,214,000 | 1.06% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 43,256,000 | $40,793,000 | 0.80% |
| Opera Trading Capital | 10,000,000 | $9,370,000 | 0.72% |
| AQR Arbitrage LLC | 52,575,000 | $49,486,000 | 0.57% |
| Neuberger Berman Group LLC | 5,000,000 | $469,375,000 | 0.54% |
| CQS Cayman LP | 12,000,000 | $11,322,000 | 0.52% |